38 results about "Nerve degeneration" patented technology

By using a G protein-coupled receptor protein containing an amino acid sequence, which is the same or the substantially the same as an amino acid sequence represented by SEQ ID NO:1, SEQ ID NO:10, SEQ ID NO:12 or SEQ ID NO:14, or its salt together with humanin, a compound or its salt capable of changing the binding properties of the above receptor protein or its salt to humanin can be efficiently screened.

The invention discloses a ganoderma lucidum extract, a preparation method and application thereof. The Ganoderma lucidum extract can be prepared by the following method: taking the broken spore powder of Ganoderma lucidum as raw material, degreasing with petroleum ether, and volatilizing until there is no ether smell; refluxing the obtained powder with ethanol for extraction, and concentrating the extract to extract. Further, the obtained extract can be made into powder, and the solid matter extracted with chloroform is then extracted with ethyl acetate, and the extract is recovered under reduced pressure and dried to obtain powdered Ganoderma lucidum extract. The extract can effectively induce nerve cell differentiation, and can be used for preparing medicines for treating nerve injury and neurodegeneration.

Method and apparatus for improving mobility in patients affected by a neurodegenerative disease, through controlled and localized mechanical stimulation of the foot, at the tip of the big toe and the lower big toe metatarsal joint. Described herein is an apparatus comprising stimulators for the right and left foot and it attains such mechanical stimulation according to predetermined intensity parameters, stimulation sequence, duration and cyclical repetition. Mobility improvement was observed in particular in patients affected by Parkinson's disease.

Methods for treatment and / or prevention of nerve degeneration in mammals using aza-peptide epoxide caspase inhibitors are provided. Aspects of the present disclosure include aza-peptide epoxide compositions to treat or prevent diseases, for example stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, neuropathies, Huntington's disease, dentatorubropallidoluysian atrophy, spinocerebellar atrophies, spinal bulbar muscular atrophy, diabetes, amyotrophic lateral sclerosis and other motor neuron diseases. The disclosed methods can be used in combination with calpain inhibitors to treat disease or pathological conditions related to the activity of caspases and calpain associated with a specific disease or condition. Such treatable conditions include stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, neuropathies, Huntington's disease, dentatorubropallidoluysian atrophy, spinocerebellar atrophies, spinal bulbar muscular atrophy, nerve degeneration associated with diabetes, amyotrophic lateral sclerosis and other motor neuron diseases, nerve degeneration secondary to primary demyelinating disorders, among others.

The present invention provides an active substance of Lactic Acid Bacteria, a composition comprising thereof and its use for promoting longevity, especially for increasing Cisd2 gene expression, reducing mitochondrial damage and delaying aging conditions such as nerve degeneration and sarcopenia.

The present invention discloses a double transgenic fly that expresses both Tau protein and the human Aβ42 peptide of human amyloid-β precursor protein (APP). The double transgenic flies of the present invention display a synergistic altered phenotype as compared to the altered phenotype displayed by transgenic flies expressing either Tau or human Aβ42 alone, and thus provide for an improved model for neurodegenerative disorders, such as Alzheimer's disease. The invention further discloses methods for identifying for therapeutic compounds to treat neurodegenerative disorders using the double transgenic flies.

Provided are compounds for the treatment of neurological diseases or injuries, including neurodegenerative diseases, stroke, trauma, epilepsy, acute and chronic kidney injuries, diabetes mellitus, and / or seizures. In some embodiments, derivatives of vitamin K are provided.